Literature DB >> 20005735

Inhibins: from reproductive hormones to tumor suppressors.

Kaye L Stenvers1, Jock K Findlay.   

Abstract

Inhibins are peptide hormones shown originally to be produced by the gonads to regulate the secretion of follicle stimulating hormone by pituitary gonadotropes. Although gonadotropes have been regarded as the canonical inhibin target cells, in recent years extrapituitary actions of inhibins have come into the spotlight. In particular, disruptions to the local actions of inhibins in peripheral tissues might underlie certain diseases, especially cancers of the reproductive tract. This review focuses on recent advances in the inhibin field, with a particular emphasis on the determinants of inhibin availability, mechanisms of inhibin action, and the physiological relevancy of local inhibin actions in the development and progression of reproductive cancers. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20005735     DOI: 10.1016/j.tem.2009.11.009

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  17 in total

1.  A new compass for activin research--a triumph for systems biology.

Authors:  Heber C Nielsen; John S Torday
Journal:  Endocrinology       Date:  2011-10       Impact factor: 4.736

2.  Decreased bone mineral density in rats rendered follicle-deplete by an ovotoxic chemical correlates with changes in follicle-stimulating hormone and inhibin A.

Authors:  A L Lukefahr; J B Frye; L E Wright; S L Marion; P B Hoyer; J L Funk
Journal:  Calcif Tissue Int       Date:  2012-01-17       Impact factor: 4.333

3.  The Local Control of the Pituitary by Activin Signaling and Modulation.

Authors:  Louise M Bilezikjian; Wylie W Vale
Journal:  Open Neuroendocrinol J       Date:  2011-01-01

4.  Immunohistochemical Analysis of E-Cadherin, p53 and Inhibin-α Expression in Hydatidiform Mole and Hydropic Abortion.

Authors:  Onur Erol; Dinç Süren; Birsel Tutuş; Tayfun Toptaş; Ahmet Arda Gökay; Aysel Uysal Derbent; Mustafa Kemal Özel; Cem Sezer
Journal:  Pathol Oncol Res       Date:  2015-12-18       Impact factor: 3.201

Review 5.  Cell-type specific modulation of pituitary cells by activin, inhibin and follistatin.

Authors:  Louise M Bilezikjian; Nicholas J Justice; Alissa N Blackler; Ezra Wiater; Wylie W Vale
Journal:  Mol Cell Endocrinol       Date:  2012-02-04       Impact factor: 4.102

Review 6.  Adult-type granulosa cell tumor of the ovary.

Authors:  Xiuwen Li; Bo Tian; Mengyan Liu; Chunlei Miao; Di Wang
Journal:  Am J Cancer Res       Date:  2022-08-15       Impact factor: 5.942

7.  Role of Betaglycan in TGF-β Signaling and Wound Healing in Human Endometriotic Epithelial Cells and in Endometriosis.

Authors:  Agnes N Mwaura; Muhammad A Riaz; Jane B Maoga; Ezekiel Mecha; Charles O A Omwandho; Georgios Scheiner-Bobis; Ivo Meinhold-Heerlein; Lutz Konrad
Journal:  Biology (Basel)       Date:  2022-03-26

8.  Betaglycan alters NFκB-TGFβ2 cross talk to reduce survival of human granulosa tumor cells.

Authors:  Maree Bilandzic; Simon Chu; Yao Wang; Han L Tan; Peter J Fuller; Jock K Findlay; Kaye L Stenvers
Journal:  Mol Endocrinol       Date:  2013-01-15

9.  Genetic variants in TGF-β pathway are associated with ovarian cancer risk.

Authors:  Jikai Yin; Karen Lu; Jie Lin; Lei Wu; Michelle A T Hildebrandt; David W Chang; Larissa Meyer; Xifeng Wu; Dong Liang
Journal:  PLoS One       Date:  2011-09-30       Impact factor: 3.240

10.  Betaglycan (TβRIII) is expressed in the thymus and regulates T cell development by protecting thymocytes from apoptosis.

Authors:  German R Aleman-Muench; Valentin Mendoza; Kaye Stenvers; Eduardo A Garcia-Zepeda; Fernando Lopez-Casillas; Chander Raman; Gloria Soldevila
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.